Low-volatility exposure across Hong Kong Southbound leaders and Korean equities.
Q2 2026 earnings release. Multiple analysts in July 2026 have forecasted that the results will exceed market consensus, driven by strong investment income. Estimated 5% price impact due to positive analyst outlook, scheduled.
Q2 2026 earnings release on 2026-08-18 with an estimated 5-10% price impact based on historical volatility scheduled
Q2 2026 earnings release scheduled for August 18, 2026. Analysts forecast a decline in operating profit compared to the previous year, citing increased costs and a high base effect, which may negatively impact short-term sentiment and dividend growth expectations, forecasted.
Q2 2026 earnings release scheduled. Multiple analysts forecast results to exceed expectations due to robust domestic and overseas sales. A 5-7% price impact is estimated based on these forecasts, scheduled.
Woori Financial Group's confirmed small-scale comprehensive share exchange will make Dongyang Life Insurance a wholly owned subsidiary. The July 24, 2026 extraordinary shareholders' meeting is Dongyang Life's approval meeting; Woori Financial does not require shareholder approval under the small-scale exchange procedure. Woori will issue up to 8,696,875 new common shares to Dongyang Life shareholders, changing Woori's outstanding share count.
The ex-dividend date for the second quarter 2026 dividend of ₩200 per share is August 7, 2026, with the payment scheduled for August 28, 2026. Low importance is estimated based on a projected price impact of at least 1%. scheduled
LG Uplus is scheduled to announce its Q2 2026 earnings on August 6, 2026. Analysts forecast a record-high quarterly operating profit, exceeding KRW 300 billion, driven by cost efficiencies and growth in the B2B sector, scheduled.
The ex-dividend date for the semi-annual dividend is August 4, 2026. The expected dividend is KRW 250 per share, with the payment scheduled for August 20, 2026, expected.
Ex-dividend date for the Q2 2026 quarterly cash dividend on 2026-07-30, with payment on 2026-08-28 and an estimated 1-2% impact scheduled
Ex-dividend date of July 30, 2026, for the second quarter dividend, with payment scheduled for August 21, 2026, scheduled.
The record date for the Q2 2026 dividend is 2026-07-30. With payment scheduled for August 28, 2026, this routine corporate action is estimated to have a 1-5% price impact, scheduled.
KRAFTON is scheduled to announce its Q2 2026 financial results on 2026-07-29. Analysts forecast revenue of 1.19 trillion KRW and operating profit of 367.1 billion KRW, driven by strong sales of 'Subnautica 2' and sustained 'PUBG' performance. A high positive impact is expected due to the significant earnings surprise expected.
Samsung Card is scheduled to announce its Q2 2026 financial results on July 28, 2026. Medium importance is estimated as earnings releases typically result in price movements exceeding 5% scheduled.
Hana Financial Group is scheduled to announce its H1/Q2 2026 earnings on July 24, 2026; estimated 5% impact as earnings are a key driver for financial stocks, scheduled.
Woori Financial Group is scheduled to release its earnings for the second quarter of 2026 on July 24, 2026, with a significant rebound in net profit compared to the first quarter analysts forecast. Medium importance is estimated based on a projected price impact of at least 5%. estimated
Analysts forecast KB Financial Group to announce record Q2 2026 earnings on July 23, 2026, with a 10% price impact estimated due to the profit scale forecasted.
Q2 2026 earnings release scheduled. Analysts forecast revenue of 1.322 trillion KRW and operating profit of 599.7 billion KRW. High importance is estimated due to the significant growth forecast likely resulting in a >=10% price impact, scheduled.
Shinhan Financial Group is scheduled to release its Q2 2026 earnings results on 2026-07-23. Analysts forecast a net profit of around KRW 1.7 trillion (+10% YoY), which would exceed market consensus and likely drive a 5-10% price impact, forecasted.
Q2 2026 earnings release scheduled for 2026-07-23. Analysts forecast a year-over-year decline in net profit due to base effects and increased provisions; medium importance estimated due to potential impact on investor sentiment, scheduled.
Partner Johnson & Johnson announced that Q2 2026 global sales of the Leclaza (lazertinib) combination therapy increased by 60.8% year-over-year to $289 million, signaling a rise in royalty income for Yuhan; estimated >5% price impact due to significant revenue growth, expected.
On 2026-07-15, KRAFTON announced its lineup for Gamescom 2026 (Aug 26-30), featuring five upcoming titles including a new unannounced game from PUBG STUDIOS. This signals a strong pipeline and IP diversification strategy.
'AX Tech Connect 2026' event on July 15, 2026, to showcase its AI transformation (AX) strategy, R&D progress, and future technologies including its proprietary AI model 'Mideum K', scheduled.
Celltrion received IND approval from the Korean Ministry of Food and Drug Safety on 2026-07-15 to begin a Phase 1 clinical trial for CT-P68. Low importance is estimated as Phase 1 approvals for biosimilars typically result in a price impact of 1-5%.
Major organizational restructuring for H2 2026 on 2026-07-14 with an estimated 1-2% impact expected
Celltrion voluntarily withdrew its European clinical trial plan for 'CT-P51' on 2026-07-14. Low importance is estimated as this strategic decision to align with regulatory trends is expected to have a minimal market impact of 1-5%.
On July 14, 2026, activist fund Align Partners publicly proposed a merger between BNK Financial Group and JB Financial Group; low importance estimated as the proposal is non-binding and lacks board approval, expected.